|
"jia horng kao"的相關文件
顯示項目 831-840 / 1180 (共118頁)
<< < 79 80 81 82 83 84 85 86 87 88 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2018-09-10T15:24:49Z |
Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection
|
Song, L.-W.;Liu, P.-G.;Liu, C.-J.;Zhang, T.-Y.;Cheng, X.-D.;Wu, H.-L.;Yang, H.-C.;Hao, X.-K.;Yuan, Q.;Zhang, J.;Kao, J.-H.;Chen, D.-S.;Chen, P.-J.;Xia, N.-S.; HUNG-CHIH YANG; CHUN-JEN LIU; PEI-JER CHEN; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:24:49Z |
Reimbursement policies in the Asia-Pacific for chronic hepatitis B
|
Lim, S.G.;Amarapurkar, D.N.;Chan, H.L.-Y.;Crawford, D.H.;Gane, E.J.;Han, K.-H.;Ahn, S.H.;Jafri, W.;Jia, J.;Kao, J.-H.;Lesmana, L.A.;Lesmana, C.R.A.;Mohamed, R.;Phiet, P.H.;Piratvisuth, T.;Sarin, S.K.;Sollarno, J.D.;Eguchi, Y.;Mahtab, M.-A.;Lee, K.H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:24:48Z |
Hepatitis B vaccination and prevention of hepatocellular carcinoma
|
Kao, Jia-Horng; Kao, Jia-Horng; JIA-HORNG KAO; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:24:48Z |
A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan
|
Bennett, H.;Waser, N.;Johnston, K.;Kao, J.-H.;Lim, Y.-S.;Duan, Z.-P.;Lee, Y.-J.;Wei, L.;Chen, C.-J.;Sievert, W.;Yuan, Y.;Li, H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:24:48Z |
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial
|
Buti, M.;Flisiak, R.;Kao, J.-H.;Chuang, W.-L.;Streinu-Cercel, A.;Tabak, F.;Calistru, P.;Goeser, T.;Rasenack, J.;Horban, A.;Davis, G.L.;Alberti, A.;Mazzella, G.;Pol, S.;Orsenigo, R.;Brass, C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2018-09-10T15:24:48Z |
Artificial ascites is feasible and effective for difficult-to-ablate hepatocellular carcinoma
|
Wang, Chia-Chi;Kao, Jia-Horng; Wang, Chia-Chi; JIA-HORNG KAO; Yang, Hung-Chih; Kao, Jia-Horng; 楊宏志 |
| 臺大學術典藏 |
2018-09-10T15:24:48Z |
Can noninvasive biomarkers replace liver biopsy for chronic hepatitis B?
|
Lin, Chih-Lin;Kao, Jia-Horng; Lin, Chih-Lin; Lin, Chih-Lin; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:24:47Z |
Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: A nation-wide cohort study
|
Huang, Y. -W.;Wang, T. -C.;Yang, S. -S.;Lin, S. -Y.;Fu, S. -C.;Hu, J. -T.;Liu, C. -J.;Kao, J. -H.;Chen, D. -S.; Huang, Y. -W.; Huang, Y. -W.; CHUN-JEN LIU; Wang, T. -C.; Wang, T. -C.; YI-WEN HUANG; DING-SHINN CHEN; Yang, S. -S.; Yang, S. -S.; JIA-HORNG KAO; Lin, S. -Y.; Fu, S. -C.; Fu, S. -C.; Hu, J. -T.; Hu, J. -T.; Liu, C. -J.; Liu, C. -J.; Kao, J. -H.; Kao, J. -H.; Chen, D. -S. |
| 臺大學術典藏 |
2018-09-10T15:24:41Z |
Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan
|
Chen, Chi-Ling; Chen, Chi-Ling; Yang, Jyh-Yuan; DING-SHINN CHEN; Yang, Jyh-Yuan; Lin, Szu-Fong; JIA-HORNG KAO; Lin, Szu-Fong; Sun, Chien-An; Sun, Chien-An; Bai, Chyi-Huey; You, San-Lin; Chen, Chien-Jen; Chen, Chien-Jen; Kao, Jia-Horng; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Pei-Jer; Chang, Sui-Yuan; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Chen, Ding-Shinn; Chen, Ding-Shinn; PEI-JER CHEN; Chen, Chi-Ling;Yang, Jyh-Yuan;Lin, Szu-Fong;Sun, Chien-An;Bai, Chyi-Huey;You, San-Lin;Chen, Chien-Jen;Kao, Jia-Horng;Chen, Pei-Jer;Chen, Ding-Shinn; Chen, Chi-Ling |
| 臺大學術典藏 |
2018-09-10T15:24:41Z |
Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection
|
Hsu, Ching-Sheng;Liu, Wei-Liang;Chao, You-Chen;Lin, Hans Hsienhong;Tseng, Tai-Chung;Wang, Chia-Chi;Chen, Ding-Shinn;Kao, Jia-Horng; DING-SHINN CHEN; Hsu, Ching-Sheng; Liu, Wei-Liang; JIA-HORNG KAO; Chao, You-Chen; Lin, Hans Hsienhong; Abbas, Z.; Tseng, Tai-Chung; Wang, Chia-Chi; Chen, Ding-Shinn; Kao, Jia-Horng |
顯示項目 831-840 / 1180 (共118頁)
<< < 79 80 81 82 83 84 85 86 87 88 > >>
每頁顯示[10|25|50]項目
|
